Nexalin Technology, Inc. (NXL)

↓ Download CSV

CIK 0001527352 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Nexalin Technology, Inc. reported revenue of $301.6K, up 78.8% from the prior year. The company ran a net loss, with a net margin of -2725.8% and a gross margin of 79.7%. It held $4.64M in total assets against $887.3K in total liabilities.

Key ratios (FY2025)

79.7%
Gross margin
-2781.7%
Operating margin
-2725.8%
Net margin
-219.4%
Return on equity
+78.8%
Revenue growth (YoY)
Metric (FY)202520242023202220212020
Revenue$301.6K$168.7K$110.7K$1.32M$144.1K
Cost of Revenue$61.4K$36.6K$25.7K$363.2K$21.4K
Gross Profit$240.3K$132.1K$85.1K$958.1K$122.6K
Operating Income-$8.39M-$7.75M-$5.70M-$1.83M-$6.02M
Net Income-$8.22M-$7.61M-$4.65M-$1.70M-$6.08M
EPS (Diluted)$-0.50$-0.83$-0.63$-0.30
Total Assets$4.64M$4.22M$3.63M$7.43M$753.7K
Total Liabilities$887.3K$546.7K$425.3K$1.95M$2.44M
Shareholders' Equity$3.75M$3.68M$3.21M$5.48M-$1.68M-$1.59M
Cash & Equivalents$654.8K$574.5K$580.2K$162.7K$661.8K
Operating Cash Flow-$4.96M-$3.94M-$3.84M-$2.22M-$1.08M
Shares Outstanding19.19M13.30M7.44M7.29M4.88M